Literature DB >> 19567598

Inhaled corticosteroids in COPD: a case in favour.

D S Postma, P Calverley.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19567598     DOI： 10.1183/09031936.00022809

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  10 in total

Review 1.  Cost effectiveness of pharmacological maintenance treatment for chronic obstructive pulmonary disease: a review of the evidence and methodological issues.

Authors:  Maureen P M H Rutten-van Mölken; Lucas M A Goossens
Journal:  Pharmacoeconomics       Date:  2012-04       Impact factor: 4.981

2.  2016 Respiratory Effectiveness Group Annual Summit Report-impact & influence of real-world respiratory evidence.

Authors:  Alison Chisholm; Nemr Eid; Bernardino Alcázar-Navarrete; Aji Barot; George Christoff; David B Price
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

Review 3.  An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease.

Authors:  Sonal Singh; Yoon K Loke
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-08-09

4.  Point of Care Portable Spirometry in the Diagnosis and Treatment of Inpatients with Chronic Obstructive Pulmonary Disease.

Authors:  Donald Tran; Melvin Lim; Sara Vogrin; Lata Jayaram
Journal:  Lung       Date:  2020-01-01       Impact factor: 2.584

5.  E pluribus plurima: multidimensional indices and clinical phenotypes in COPD.

Authors:  Andrea Rossi; Erika Zanardi
Journal:  Respir Res       Date:  2011-11-14

Review 6.  Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease--The Shifting Treatment Paradigm.

Authors:  Morven Wilkie; Simon Finch; Stuart Schembri
Journal:  COPD       Date:  2015-03-16       Impact factor: 2.409

7.  Is Blood Eosinophil Count a Biomarker for Chronic Obstructive Pulmonary Disease in a Real-World Clinical Setting? Predictive Property and Longitudinal Stability in Japanese Patients.

Authors:  Koichi Nishimura; Masaaki Kusunose; Ryo Sanda; Mio Mori; Ayumi Shibayama; Kazuhito Nakayasu
Journal:  Diagnostics (Basel)       Date:  2021-02-27

8.  Inhaled corticosteroids in COPD and the risk of serious pneumonia.

Authors:  Samy Suissa; Valérie Patenaude; Francesco Lapi; Pierre Ernst
Journal:  Thorax       Date:  2013-11       Impact factor: 9.139

9.  Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns.

Authors:  David Price; Daniel West; Guy Brusselle; Kevin Gruffydd-Jones; Rupert Jones; Marc Miravitlles; Andrea Rossi; Catherine Hutton; Valerie L Ashton; Rebecca Stewart; Katsiaryna Bichel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-08-27

10.  Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function.

Authors:  Kylie Br Belchamber; Catherine Mr Thomas; Amy E Dunne; Peter J Barnes; Louise E Donnelly
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-09-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.